Literature DB >> 23925288

Treatment of congenital chylothorax with octreotide in a hydropic preterm infant.

Yao Mun Choo1, Chin Theam Lim.   

Abstract

Congenital chylothorax is rare in preterm infants. While most cases respond to conservative treatment, a few require surgery. Treatment with intravenous octreotide has been reported to have varying success in preterm infants. A fetus was diagnosed with bilateral hydrothoraces at 29 weeks of gestation and repeated thoracocentesis was performed antenatally to allow growth of the lungs. She was delivered electively at 32 weeks by caesarean section. Hydrops fetalis was confirmed and chest tubes were inserted bilaterally soon after birth. Intravenous octreotide was commenced on day 4 of life, titrated to a maximum of 10 μg/kg/hr for a total of 28 days. Hydrothorax resolved at day 30 and total parenteral nutrition was given for a total of 37 days. She was successfully extubated on day 40 of life and discharged on day 80. On review at 6 months of age, she was thriving and developing normally.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23925288     DOI: 10.1179/2046905512Y.0000000030

Source DB:  PubMed          Journal:  Paediatr Int Child Health        ISSN: 2046-9047            Impact factor:   1.990


  2 in total

1.  Congenital Chylothorax of the Newborn: A Systematic Analysis of Published Cases between 1990 and 2018.

Authors:  Bernhard Resch; Gülsen Sever Yildiz; Friedrich Reiterer
Journal:  Respiration       Date:  2021-09-01       Impact factor: 3.580

2.  Treatment of persistent congenital chylothorax with intrapleural injection of sapylin in infants.

Authors:  Qing-Wang Hua; Zhi-Yong Lin; Xing-Ti Hu; Qi-Feng Zhao
Journal:  Pak J Med Sci       Date:  2016 Sep-Oct       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.